News of Affy s Faulty Chips Serves As Reminder of Perils of Public Data | GenomeWeb

Publicly available genomics data may be one of the most important resources for researchers, but as Affymetrix recently learned, the information does carry its share of risks.

Last week Affymetrix said that due to ambiguities in the publicly available UniGene database, the company had misinterpreted the data and put down sequence information from the wrong strand of DNA. As a result Affymetrix may take up to a $4 million hit as well as a loss in some of its credibility.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.